Cargando…
Management of liver disease patients in different clinical situations during COVID-19 pandemic
Chronic liver diseases are common worldwide, especially in developing countries. The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/(COVID-19) leads to the infection of many patients with underlying chronic liver diseases. As a relatively new disease, management of COVI...
Autores principales: | Zaky, Samy, Alboraie, Mohamed, El Badry, Mohamed, Metwally, Mohamed A., Abdelaziz, Ahmed, Fouad, Yasser, Abd-Elsalam, Sherief, Mahmoud, Abdelmajeed, Shiha, Gamal, Baki, Amin Abdel, El Kassas, Mohamed, Esmat, Gamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994958/ https://www.ncbi.nlm.nih.gov/pubmed/34777868 http://dx.doi.org/10.1186/s43066-021-00091-x |
Ejemplares similares
-
Eliminating hepatitis C from countries with high prevalence: When infrastructure comes first
por: Esmat, Gamal, et al.
Publicado: (2021) -
New era for management of chronic hepatitis C virus using direct antiviral agents: A review
por: Elbaz, Tamer, et al.
Publicado: (2015) -
Predictors for Severity of SARS-CoV-2 Infection Among Healthcare Workers
por: El-Raey, Fathiya, et al.
Publicado: (2021) -
Egyptian Consensus on the Role of Lung Ultrasonography During the Coronavirus Disease 2019 Pandemic
por: Zaky, Samy, et al.
Publicado: (2022) -
Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village
por: Ahmed, Ossama Ashraf, et al.
Publicado: (2018)